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Background: Estimates show that as many as one in 10 patients are harmed while receiving hospital care. Previous
strategies to improve safety have focused on developing incident reporting systems and changing systems of care
and professional behaviour, with little involvement of patients. The need to engage with patients about the quality
and safety of their care has never been more evident with recent high profile reviews of poor hospital care all
emphasising the need to develop and support better systems for capturing and responding to the patient
perspective on their care. Over the past 3 years, our research team have developed, tested and refined the PRASE
(Patient Reporting and Action for a Safe Environment) intervention, which gains patient feedback about quality and
safety on hospital wards.
Methods/design: A multi-centre, cluster, wait list design, randomised controlled trial with an embedded qualitative
process evaluation. The aim is to assess the efficacy of the PRASE intervention, in achieving patient safety
improvements over a 12-month period.
The trial will take place across 32 hospital wards in three NHS Hospital Trusts in the North of England. The PRASE
intervention comprises two tools: (1) a 44-item questionnaire which asks patients about safety concerns and issues;
and (2) a proforma for patients to report (a) any specific patient safety incidents they have been involved in or
witnessed and (b) any positive experiences. These two tools then provide data which are fed back to wards in a
structured feedback report. Using this report, ward staff are asked to hold action planning meetings (APMs) in order
to action plan, then implement their plans in line with the issues raised by patients in order to improve patient
safety and the patient experience.
The trial will be subjected to a rigorous qualitative process evaluation which will enable interpretation of the trial
results. Methods: fieldworker diaries, ethnographic observation of APMs, structured interviews with APM lead and
collection of key data about intervention wards. Intervention fidelity will be assessed primarily by adherence to the
intervention via scoring based on an adapted framework.
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Discussion: This study will be one of the largest patient safety trials ever conducted, involving 32 hospital wards.
The results will further understanding about how patient feedback on the safety of care can be used to improve
safety at a ward level. Incorporating the ‘patient voice’ is critical if patient feedback is to be situated as an integral
part of patient safety improvements.
Trial registration: ISRCTN07689702, 16 Aug 2013
Keywords: Patient safety, Safety management, Medical error, Patient participationBackground
The public expect safety to be a priority within health
services. However, estimates show that as many as one
in 10 patients are harmed while receiving hospital care
[1-4]. Healthcare associated harm is defined as arising
from or associated with plans or actions taken during
the provision of healthcare, rather than an underlying
disease or injury [5]. One study of admissions analysed
over a 5-year period across 10 hospitals in the Unites
States [6] found that 63% of all harms were deemed pre-
ventable. The recent UK NHS Mandate [7] lists one of
its core themes as: ‘treating and caring for people in a
safe environment and protecting them from avoidable
harm’, with the objective of reducing avoidable harm and
embedding a culture of patient safety in the NHS by
2015. Accordingly, patient safety has been firmly posi-
tioned as a key NHS and government concern. Patient
involvement in healthcare safety is also a policy priority
with, for example, the World Health Organization’s
World Alliance for Patient Safety (WHO, WAPS) citing
mobilisation and empowerment of patients as one of six
action areas that will be taken forward in its ‘Patients for
Patient Safety’ programme [8].
Strategies to improve safety have focused on develop-
ing incident reporting systems, and changing systems of
care and professional behaviour. However, there has re-
cently been a growing interest in involving patients in
safety initiatives. This reflects recent UK government
policy aims for people to be generally more involved in
their care [9,10]. High profile reviews of poor UK hos-
pital care [11-13] have all emphasised the need to de-
velop and support better systems for capturing and
responding to the patient perspective on their care.
However, it is imperative that such systems are robustly
developed and evaluated, and moreover, integrated into
existing clinical governance systems within healthcare
organisations [14].
Despite international emphasis on patient involvement
in safety there is a dearth of research evidence on the ac-
ceptability of this involvement to patients and equivocal
evidence to date on whether such involvement leads to
improvements in safety. The evidence that exists indi-
cates that patients are willing and able to participate in
error prevention strategies [15] which have the potentialto improve safety [16-19]. However, many factors hinder
patient participation including acceptance of the new pa-
tient role, lack of medical knowledge, lack of confidence,
co-morbidity and sociodemographic factors [20]. Thus,
there is clearly a need to understand further how pa-
tients can best be involved in safety initiatives and the
effectiveness of such involvement in improving safety.
Reason’s model of organisational safety [21] states that
organisational accidents are a result of a number of fac-
tors including active failures on the part of the individual
(for example, attentional slips, or mistakes in decision
making), and ‘systems failures’ encompassing latent fail-
ures (for example, budgeting or rostering decisions) and
local working conditions (for example, equipment un-
available, ward or unit understaffed). Systems failures are
often referred to as ‘contributory factors’. Based on these
ideas, measurement tools have been developed in high-
risk industries to monitor organisations’ ‘safety health’
[22,23]. However, currently no general means of asses-
sing organisational safety or ‘systems’ failures exists
within the NHS. Furthermore, no specific measures of
organisational safety exist that ask for the views of pa-
tients, despite patients being well placed to observe the
organisation of their care and the practices around them.
Therefore, there is a need for reliable and valid tools that
allow patients the opportunity to provide feedback on
the safety of their care environment to inform local and
organisational changes to improve patient safety.
Learning from error is a key element of patient safety
[24], and one way to learn is through the reporting and
analysis of patient safety incidents. A patient safety inci-
dent (PSI) has been defined as ‘any unintended or unex-
pected incident which could have or did lead to harm
for one or more patients receiving NHS care’ [25]. This
definition usefully encompasses a variety of situations re-
lating to patient safety, across both adverse events them-
selves and near misses. Historically, efforts to learn from
incident reports have been focused on staff-led reporting
systems [26], with little attention paid to the potential of
the patient as a valuable source of information about pa-
tient safety [18,27-30]. Indeed, it has been argued by
some authors that the patient is uniquely placed to con-
tribute to the quality and safety of their own care [31],
with recent empirical work demonstrating the feasibility
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study to date has attempted to systematically develop
and evaluate the most effective method of patient
reporting. In addition, no study has attempted to link
reporting of patient safety incidents to mainstream qual-
ity improvement mechanisms.
During the last 3 years, our research team have devel-
oped and tested the Patient Measure of Safety (PMOS)
[36,37] and the Patient Safety Incident Reporting Tool
(PIRT). Together, these tools form the PRASE (Patient
Reporting and Action for a Safe Environment) interven-
tion which asks patients about the safety and quality of
their care. PMOS is a 44-item questionnaire and PIRT is
a reporting proforma. Patient feedback is collated into a
report from which ward staff formally action plan and
implement changes - in line with the issues raised by pa-
tients - with a view to improving patient safety and the
patient experience. More detail about the intervention is
given in the Methods section.
PRASE has recently been piloted in a trial of over 300
participants in a medium-sized hospital in the North of
England. This pilot has allowed the research team to test
key feasibility, usability and logistical issues. Much of
the development of the intervention to date and associ-
ated work has been published elsewhere [36-38]. This
paper provides the protocol for the current study which
will test the PRASE intervention in a multi-centre,
cluster randomised controlled trial, employing a wait list
design.
Methods/design (trial)
Primary objective
To assess the effectiveness of the PRASE patient safety
intervention, in achieving patient safety improvements
over a 12-month period.
Design
A multi-centre, cluster randomised controlled trial, ran-
domising wards to either intervention or control in a 1:1
ratio.
The PRASE intervention process
The PRASE intervention is designed to collect feedback
from patients about the safety of their care, using robust
tools developed within our team over the past 3 years.
This patient feedback is then collated and presented to
each ward in a formal report (a ‘feedback report’). This
report then allows ward staff to understand more about
how patients perceive the safety of their care on their
ward, and then target improvements based on problem-
atic areas. The philosophy of this intervention is that it
is an iterative process with a cycle of measurement, feed-
back and change lasting for a period of 6 months. Thethree key stages of the process are: a) measurement, b)
feedback, c) action planning and change.
a) Measurement
Over a 3- to 4-week period, an average of 25 patients
per ward will be recruited to participate in the measure-
ment phase. Each patient (deemed to have capacity to
consent) will be approached, the study explained, and in-
formed consent taken. Following this, and using a com-
puter tablet, the research fellow or research nurse will
ask the patient to complete the 44-item PMOS question-
naire, and report any safety concerns (or specific positive
experiences of care) using the PIRT incident reporting
tool. The 44-item questionnaire asks questions based on
eight different domains which are:
 communication and team working
 organisation and care planning
 access to resources
 ward type and layout
 information flow
 staff roles and responsibilities
 equipment
 delays
An additional four questions are asked, which are de-
scribed under the Secondary Outcomes section. Patients
will be given a choice of whether they would prefer to
self-complete the questionnaire or have it facilitated by
the researcher. Patient reports of safety concerns (or
positive reports) can only be recorded in a facilitated
conversation with a researcher, due to the need to elicit
detailed information in a specific format that needs to
be typed onto the computer tablet. The PMOS question-
naire and PIRT tool are detailed in Additional file 1:
Appendix 1 and Additional file 1: Appendix 2.
There are three measurement periods – at baseline, at
6 months, and a final measurement at 12 months.
b) Feedback
Following the measurement period, the information
for each ward will be collated and presented to the ward
in the form of a ‘Feedback Report’. This report provides
a variety of different qualitative and quantitative infor-
mation for staff, and has been designed and piloted by a
team of patients, academics and health professionals to
be as user friendly as possible. Please see Additional
file 1: Appendix 3 for an example of the feedback report.
The report provides an overall ward safety profile (on
pages 3 and 4) which summarises scores and number of
reports (concerns or positive experiences) relating to each
contributory factors domain of the PMOS questionnaire,
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and reports relate to specific questions. PMOS question-
naire scores are shown graphically using a traffic light
system to allow staff to see where they are performing
well, and where improvements are necessary.
No recommendations for areas of action are suggested
by the research team. The feedback report is simply a
reflection of the patient’s perspective of the safety of
their care. It is then up to ward staff to identify areas to
target for improvement, within the next phase of the
intervention.
c) Action planning and change
The next phase of the intervention is action planning,
followed by implementing and monitoring changes,
based on the areas identified for action in the feedback
report. To undertake the action planning, we will ask
participating wards to identify an Action Planning Team
(APT). This team will comprise a minimum of four
people who work on the ward, and ideally include both
senior and more junior staff, from different professional
groups. An example action planning team might include
any of the following representatives: matron, consultant,
ward manager/ward sister, junior doctor, staff nurse,
healthcare assistant, Allied Health Professional (for ex-
ample, a physiotherapist, an occupational therapist),
pharmacist, ward clerk or patient representative. The
APT will be responsible for receiving the feedback re-
port, considering which area(s) should be targeted, and
agreeing an action plan for improvement. In addition,
the team will need to monitor the implementation of the
plan. A nominated person within the APT will take re-
sponsibility for delivering the action plan.
Action Planning Meetings (APMs) will be facilitated
by a senior researcher from the Quality & Safety re-
search team. The piloting of the PRASE intervention
showed that facilitation of APMs was important for gen-
eration of concrete action plans as an outcome of the ac-
tion planning meeting.
Control wards will receive no intervention during the
study duration. At the end of the study, control wards
will receive all their feedback reports for the three time
points of data collection amalgamated into one report.
Setting and sample
This study will be undertaken within 32 hospital wards,
spread across three NHS Trusts, over five different hos-
pital sites (eight wards at a small district general hos-
pital, 10 wards at a medium sized teaching hospital and
14 wards at a very large teaching hospital). Study partici-
pants will be patients within participating wards. An
average of 25 patients within each ward will be recruited
at three different time points across the study period.Each time point lasts 3 to 4 weeks and data collection
occurs within the same 3- to 4-week window for all par-
ticipating wards in the same Trust. The eligibility criteria
for the study are given below but, briefly, the selection
criteria for participation is: any patient aged 16 years or
over who has capacity to give informed consent to take
part. All patients who satisfy the eligibility criteria are
approached and then if they agree to take part in the
study and give informed consent then they are recruited
into the study. Therefore, selection bias is minimal as re-
searchers approach every patient on the ward in a step-
wise fashion, unless the patient does not have mental
capacity to give informed consent or they are so gravely
ill or distressed to the extent that it would preclude the
researcher undertaking the PMOS questionnaire with
them. Recruitment of patients on a ward ceases when 25
patients have been recruited. The study will involve 800
patients at each time point and equates to a total sample
of 2,400 patients. While study participants are patients,
the outcome measures are at ward-level meaning that
the unit of analysis is the ward.
Wards will be randomly assigned to either the inter-
vention or control groups, on a 1:1 ratio. Randomisation
will be carried out by York Trials Unit Randomisation
Service (based at the University of York) using a secure
computer system. All wards from each Trust will be ran-
domised in a batch. Although there is the possibility of
staff moving between control and intervention wards in
a hospital, the possibility of contamination between the
groups is expected to be minimal. This is because the
‘Feedback Report’ is not available to control wards and
the intervention is ward-specific dependent on this.
Baseline data collection will be undertaken at least 1
month before randomisation to ensure completion of
data collection before knowledge of randomisation.
Once baseline data have been collected in a Trust, par-
ticipating wards will be randomly allocated to one of the
two arms: intervention or control. Minimisation will be
used to balance the groups with respect to ward
specialty, average age, single/mixed sex wards and ward
size. After randomisation, ‘start up’ meetings will be held
with intervention wards only. Intervention wards will
be asked to set up action planning meetings in order
to consider their first feedback report. The above
process is detailed in flow chart format in Additional
file 1: Appendix 4.
Blinding
Data collectors will be blind as to which wards are in
the intervention group and which are in the control
group, in order to minimise bias in data collection.
Blinding of the senior researchers working on this study
is not possible as they are facilitating the action planning
meetings which take place with intervention wards only.
Sheard et al. Trials 2014, 15:420 Page 5 of 12
http://www.trialsjournal.com/content/15/1/420Inclusion criteria
– Male or female
– Aged 16 years or over
– Able to give informed consent
– Minimum period of 4 h on the ward before
questionnaire administered
Exclusion criteria
– Does not have capacity to consent
– Child under the age of 16 years
– Has capacity but is too ill or distressed to take part
(for example, breathlessness, pain, bleeding,
immediately postoperative)
– Has already taken part in the study within the
previous month
Estimate of sample size
The study will be powered to detect a small to medium
difference (effect size = 0.3) between the intervention
and control groups with respect to the Patient Safety
Thermometer score (See Outcome Measures for explan-
ation of this score). A small to medium effect size seems
a reasonable assumption as each ward will be focussing
on developing and implementing their own action plans,
tailored using their initial feedback. The intervention is
therefore specific to individual wards and may not
impact on all areas measured by the Patient Safety
Thermometer. In order to achieve 80% power (with
alpha = 0.05) with an average cluster size of 25 patients
and assumed ICC of 0.05, 32 wards will be required
(16 per arm). This estimate of ICC seems reasonable
for a trial in secondary care with a patient reported
outcome [39].
Study period
The study will run for 16 months in each ward. We will
stagger the start date for each trust, and for different
wards in each participating trust, to allow effective man-
agement of the patient recruitment process.
Outcome measures
The PRASE intervention wards receive patient feedback
directly relevant to their area, and then identify areas for
improvement and plan targeted changes on the basis of
the areas identified. The lack of a focus on a specific
safety outcome means that more generic measures of
safety are necessary.
Primary outcome measures will be:
1) Patient Safety Thermometer data. These are
routinely collected hospital ward level data which allwards in England are mandated to collect on a
monthly basis. It collects data about:
a. pressure ulcers
b. newly acquired venous thromboembolisms
c. catheter associated Urinary Tract Infections
d. falls
An overall measure of harm-free care is then calcu-
lated per ward. The outcome can range between 0 and
100, with higher scores indicating a higher percentage of
harm-free care.
2) PMOS questionnaire domain scores. The 44-item
questionnaire is scored into nine domains and one
single item.
Secondary outcome measures:
1) Three Commissioning for Quality and Innovation
questions (from patients, at the end of the
questionnaire) which are:
– Were you involved as much as you wanted to be
in decisions about your care and treatment? (Yes,
definitely/Yes, to some extent/No)
– Did you find someone on the hospital staff to talk
to about your worries and fears? (Yes, definitely/
Yes, to some extent/No/I had no worries or fears)
– Were you given enough privacy when discussing
your condition or treatment? (Yes, always/Yes,
sometimes/No).Each question will be considered separately with the
proportion of patients responding in the ‘Yes’ categories
combined for analysis purposes.
2) Family & Friends question, which is: ‘How likely are
you to recommend this ward to friends and family if
they needed similar care or treatment?’
Patients can respond on a 5-point Likert scale (ex-
tremely likely, likely, neither likely nor unlikely, unlikely,
extremely unlikely). The proportion reporting ‘Extremely
likely’ and ‘likely’ will be used in the analysis.
3) Staff safety culture (Additional file 1: Appendix 5),
including:
a. Ten questions from NHS national annual staff
survey included items pertaining to ‘working on
the ward’, ‘staff contribution to patients’, and
‘improving work practices’.
b. Four questions from the Hospital Survey of
Patient Safety regarding
– perceptions of patient safety (mean of 4
items, ranging from 1.0 to 5.0 with 1
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a high score)
– frequency of event reporting (mean of 3
items, ranging from 1.0 to 5.0 with 1
representing a low score and 5 representing
a high score)
– number of events reported in the last
12 months (1 item, categorical scale)
– a ward patient safety grade from 1 to 5
(1 = excellent, 5 = failing).We will also seek to access from the trusts some rou-
tinely collected ward-level data from participating wards:
– Patient safety incidents for the study period will be
collected using standard incident reporting by staff
to the regulatory authorities. Standard reporting of
patient safety incidents will be categorised into harm
and no harm events.
– Complaints and comments reported to NHS
Patient Advice Liaison Service (as a secondary
outcome)
– Ward level covariates (staff absence/sickness rates,
nurse/patient ratios and number of discharges per
month) will also be collected for exploration in the
analysis.
These data will be collected at baseline, 6 months and
12 months apart from the Staff Safety Culture which will
be collected at baseline and 12 months.
Management of the intervention
The agreement of senior management at the three NHS
Trusts (at CEO, Chief Nurse or Medical Director level)
has already been gained and participating wards identi-
fied. On the basis of previous work undertaken by our
team, we realise it is important to get both ‘top-down’
agreement as well as ‘bottom-up’ engagement with ward
staff, in order to secure the time, resources and motiv-
ation required to participate in such an intervention. To
this end, within each participating trust, we will run a
series of three, 2-h group ‘Trust debrief ’ sessions with
the identified APTs from the trust. The first will be a
‘start-up session’, which will run after the first phase of
data collection has commenced but before any action
planning meetings have begun. The primary purpose of
this meeting will be to provide a more detailed briefing
about the PRASE intervention, its conceptual basis, how
it will work, and what is required of the APTs. A sec-
ondary purpose of this meeting will be to bring together
all of the intervention wards, to identify potential bar-
riers to the action planning process and share ideas
about how best to manage them. The second meeting
will be at 6 months. This ‘mid-point’ meeting will be toreceive updates from each of the APTs about progress,
share their success as well as trouble-shoot any prob-
lems, elicit support from senior management where in-
terventions require resources and generally try to
maintain motivation for the intervention and the study.
The final ‘closing’ meeting will be for the APTs to share
their experience of PRASE, discuss changes they have
implemented, and allow the research team to gain
contextual information about the ward which may affect
the outcome measures (see process evaluation section
below). Where these debriefing sessions sit in the
timeframe of the trial is detailed in Additional file 1:
Appendix 4.
Recruitment and informed consent
Patients will be recruited by researchers from Bradford
Teaching Hospitals NHS Foundation Trust alongside re-
search nurses employed by the Trust in which they are
collecting the data. A 1-day training course will be given
to research nurses external to the core research team.
Researchers will liaise with nursing staff on each ward to
identify patients who have capacity and are considered
well enough to take part in the research. Researchers will
then approach appropriate patients to give them infor-
mation about the study, both written (in the form of a
participant information sheet) and verbally. The sheet
will explain why the research is being conducted and
what is involved in taking part. If the patient agrees to
take part then informed consent will be gained and the
patient will then be recruited into the trial. Patients will
be informed that they can withdraw at any time without
giving a reason. They will be assured that the decision to
withdraw or to not take part will not affect the standard
of care they receive. All additional relevant study infor-
mation will be made available to participants on request
(for example, copies of the research protocol). The
process of recruitment and gaining informed consent
has already been piloted in preliminary phases of this
study and the research team are well versed in engaging
and recruiting patients on hospital wards in a respectful
and sensitive manner.
Approvals process
 NHS Research Ethics Committee approval was
granted by South Yorkshire REC on 15th March
2013 (13/YH/0077)
 NHS Research Governance approval for:
– Harrogate & District NHS Foundation Trust on
3rdMay 2013
– Calderdale & Huddersfield NHS Foundation
Trust on 17th May 2013
– Leeds Teaching Hospitals NHS trust on 30th
May 2013
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Trial analysis
A full Statistical Analysis Plan will be written prior to
any analyses. Analyses of individual level outcomes will
account for clustering. For the primary outcomes, the
difference between intervention groups will be estimated
with 95% confidence intervals. The intervention groups
will be compared with respect to the proportion of
harm-free care across wards at 12 months. A linear re-
gression model accounting for the minimisation factors
and the baseline level of harm-free care will also be in-
cluded as a covariate. As the outcome measure is on a
ward level, no adjustment for clustering is required. The
difference between the intervention groups at 12 months
will be calculated with a 95% confidence interval. The
standardised effect size will also be reported.
Multi-item PMOS domains will be treated as con-
tinuous data in the analysis. Linear mixed models
accounting for the minimisation factors and baseline
PMOS scores (ward level averages) will be used to com-
pare the intervention groups with respect to each do-
main score at 12 months. Random effects will be used to
account for the clustering at ward level. The difference
in adjusted (least square) means will be summarised
with 95% confidence intervals. Standardised effect size
and ICC will also be calculated. Due to the nature of the
intervention it is not possible to identify which domains
are of primary interest, since the intervention across dif-
ferent wards may focus on improving different domains.
Each domain will therefore be tested without adjustment
for multiplicity. Interpretation of the P values will be
considered carefully alongside the full details of which
domain(s) the interventions in each ward were aiming to
improve.
Secondary outcomes will be analysed using similar
models to the primary outcomes. Ward level covariates
will be added to the primary model in order to explore
their influence. Continuous measures will be compared
between groups using multi-level regression modelling
accounting for trust/ward where required and the mini-
misation factors. Categorical measures will be compared
between groups using logistic regression (or ordinal
logistic regression for ordinal measures) adjusting for
the Trust/ward where required and minimisation factors.
The validity and reliability of the PMOS and domain
scores will be investigated in this population using
Cronbach’s alpha and known-group comparisons. All
primary and secondary outcome measures will be sum-
marised at each time point and by intervention group
using summary tables or graphs/bar charts depending
on the type of data.Methods/design (process evaluation)
The trial will be subjected to a rigorous qualitative
process evaluation. Process evaluations within trials ex-
plore the: (1) implementation; (2) receipt; and (3) setting
of an intervention and help in the interpretation of the
outcome of results [40]. This can help improve the valid-
ity of the intervention findings alongside helping to ex-
plain specific reasons why an intervention succeeded or
failed [41]. A process evaluation answers the question
‘where does the intervention work, how and why?’. A
key component of a process evaluation is that of imple-
mentation ‘fidelity’ which measures the degree to which
an intervention was implemented as intended [42].
The methods used to conduct a process evaluation of
the trial will be:
 detailed fieldworker diaries
 in-depth ethnographic observation of the APMs
 telephone interviews with APM lead
 brief questionnaire to all staff
 collection of key information from intervention
wards
The timescales for these process evaluation methods
have been mapped onto the main trial timescales and
detailed in Additional file 1: Appendix 6.
a) Researchers will keep qualitative fieldwork diaries
during the life of the trial to record their daily
thoughts about what is occurring ‘on the ground’.
Fieldwork diaries are informed by their regularity
and personal and contemporaneous nature [43]. It is
expected that researchers will write entries several
times a week. The content of the diaries will focus
on the culture or dynamics of a ward that may
hinder or support intervention implementation
alongside the fieldworker’s own personal reflection
on events that have taken place [43]. Researchers
will meet regularly to ensure that momentum is
maintained with diary writing and to review the
content to examine similarities and differences in
research experiences on certain wards. Findings
from these diaries will help inform how the trial has
been implemented and received by the wards. In the
pilot study, we are already implicitly aware of how
different cultures on different wards may have
influenced how the intervention was implemented
and how much of this can be identified by the
fieldworkers on site. Recording of this tacit
knowledge will improve the validity of the
intervention findings.
b) One of the most important processes to occur
within this trial is that of the action planning
meeting (APM) where members of staff on
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feedback reports based on the safety data generated
from patients responses. Correspondingly, APMs
form the most ‘active ingredients’ of this trial as the
teams digest the information from the feedback
reports and consider which action plans to make.
It is therefore vital that in depth ethnographic
observation of these meetings forms a core part of
the process evaluation if the research team are to
understand how the intervention works. A research
team using an intervention to improve lung cancer
outcomes [42] found that observation of MDT
meetings was a core element of their evaluation.
The APM will be digitally recorded to allow the
researchers to ‘revisit’ the meeting at a later date.
Researchers will make detailed field notes straight
after the APM has finished. They will start by
making descriptive observations to describe ‘what,
who, where and how’ [43] and then focus on
processes occurring during the APM. Processes may
include meanings, spaces, participation, relationships
and settings [44]. A highly detailed account will be
maintained. The last stage will be the researcher’s
own interpretations of the observational period
paying attention to the minutiae of how the ward
staff have received the intervention, how they relate
to each other as a team regarding the trial and how
they plan action points.
c) Short, structured telephone interviews will be
undertaken with the nominated PRASE lead for
each intervention ward involved in the APM.
Participants will be asked to rate the implementation
of their action plans by attributing Yes, Partial or No
to each action plan. Interviewers will then probe for
context as to why action plans were only partially or
not implemented alongside ascertaining how
successful action planning was achieved. Additional
open ended questioning will primarily focus on how
engaged and satisfied APM members were with the
intervention. Interviews will be undertaken at
6 months and 12 months into the trial.
d) At the 12-month stage, a brief questionnaire will be
dovetailed into the staff safety culture survey. We
will include four items to measure the ‘reach’ of the
intervention, that is, how far the knowledge of the
intervention has spread among staff on the ward
who are not involved in the action planning group
e) The collection of key information from intervention
wards is an important part of this process
evaluation. The research team will monitor the
following:
– Did the ward staff attend an action planning
meeting which was facilitated by a researcher
from the PRASE team?– How many times a ward postponed or cancelled
an APM, if any?
– Were action plans made by the ward?
– Is there any documented evidence of this?
– Did the ward take part in a telephone interview
about the study?
– Attendance at whole-Trust meetings (start-up,
mid-point, closing)Process evaluation analysis
a) Fieldworker diaries - these will be read and
interrogated for common themes arising from the
notes that differing researchers have made. The
diaries kept during the first data collection period
will be used to formulate a more prescriptive
template for diary recording in the second and third
data collection periods. It is likely that information
will emerge about the hospital Trusts in general and
then more specifically about individual wards. At
this point in time, it is unknown what fieldworkers
will write about and therefore diary writing during
the phase one data collection period is a pilot
activity in itself in order to produce a diary template
for the second and third data collection periods.
However, all data arising from this period will be
treated as real data and included in the final analysis.
We expect diary data to be subject to a thematic
analysis, using a framework analysis structure [45].
b) In depth ethnographic observation of APMs - An
examination of the digital tape recording of the
APM will focus on core themes related to action
planning. These may include an examination of:
– The rationale behind the action plans which the
group chose to make
– Whether ward staff chose to make systemic,
upstream plans or chose ‘quick fixes’ and the
context behind this
– Potential action plans which were discussed but
not acted upon and the reasons why (including
financial, logistic, cultural or other constraints)These explicit data regarding what the APT discussed
will be synthesised with the implicit data gathered from
the facilitator’s field notes. This will give a comprehen-
sive qualitative account of each APM. Both data sources
will be synthesized and analysed, using techniques de-
rived from adaptive theory [46]. We anticipate that this
analysis may provide explanatory power for the PMOS
scores alongside an understanding of wider, contextual
organisational issues at play.
c) Structured interviews - An a priori coding
framework will be devised, structured around key
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partially successful or failed to be implemented. This
could include concepts of autonomy, ownership or
resource. However, the coding framework will also
give flexibility to data that arise from the participants
themselves. Similarities and differences will be
interrogated between wards - particularly in the
same Trust - to understand how similar action plans
were implemented on some wards but not on others
and the rationales behind this. Findings related to
engagement and satisfaction with the intervention
will point the research team towards which elements
of the study ward staff may have struggled with and
which elements they embraced.
d) Questionnaire to all staff - Mean scores on four
Likert questionnaire items will provide an indication
of the extent to which ward staff have been exposed
to the different aspects of the intervention, for
example, the data collection, feedback, action
planning and implementation of actions. A summed
score across these four items will be used as a
measure of ‘reach’ in the main trial analysis.
e) Collection of key information from intervention
wards - The recording of key factual information
listed above will enable ‘scores’ to be derived
regarding the basic fidelity of the intervention
implementation for each ward (see next section for
further details).
Assessment of fidelity
An assessment of fidelity is an important component of
the evaluation of complex interventions, sometimes de-
scribed as the ‘black box’ of interventions [47]. Following
Hasson et al. [41,48] and Carroll et al. [49], we propose
a systematic assessment of implementation fidelity of the
PRASE intervention. The framework for this assessment
is outlined in Additional file 1: Appendix 7, and is an
adapted version of the Conceptual Framework for Im-
plementation Fidelity [49], which has recently been used
successfully in a health service intervention [48]. Three
of the authors (RL, LS, JoH) agreed the key components
of the intervention, and then which components were
appropriate for the fidelity assessment. Some com-
ponents were not deemed appropriate for a fidelity
assessment as this aspect of the intervention is under
the direct control of the research team (for example,
‘collection of feedback from patients about safety inci-
dents and positive experiences of care’; see Additional
file 1: Appendix 7 for other examples).
Adherence will be assessed for each intervention
component, which are:
 Attendance and contribution to pan-Trust Start
Up Meeting Holding a multi-disciplinary Action Planning
Meeting to consider patient feedback about safety
and quality (x 2 per intervention ward)
 Creation of action plans in response to patient
feedback
 Implementation of action plans
 Attendance and contribution to pan-Trust
Mid-Point Meeting
 Attendance and contribution to pan-Trust Closing
Meeting
Other components of the intervention exist but these
are not subject to fidelity adherence as they are re-
searcher controlled (see Additional file 1: Appendix 7)
We will use the following criteria to assess each of the
above listed intervention components:
 Content - was the intervention component
implemented as planned?
 Reach - what proportion of the target group
participated in this intervention component?
Following Hasson et al. [41,48] and Carroll et al. [49],
the authors also agreed which of the potential moderat-
ing factors may impact on the adherence of participating
wards in each of the fidelity components. Only three po-
tential moderating factors were selected, as the others
were deemed to be under the control of the researchers
within the study. The three selected were:
 Context (including management support) - what
factors at political, economic, organizational and
work group levels affected the implementation?
 Responsiveness - how were the participants engaged
with the intervention component? How satisfied
were the participants with the intervention
component? How did the participants perceive
the outcomes and relevance of the intervention
component?
 Quality of delivery - how was the quality of
delivering the intervention components?
These moderating factors will be assessed using data
from the process evaluation, utilising whichever method
(s) give the most accurate data to answer the relevant
moderating factor question. For instance, it is antici-
pated that the first question under ‘responsiveness’ will
be assessed via the observation of the APMs and facilita-
tors’ notes while the second and third questions will be
assessed from data gathered in the structured telephone
interview stage.
Adherence to the different intervention components
will be ‘scored’ on a categorical scale ranging from 0 to
3, with 0 representing ’no adherence’, 1 representing
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representing ‘full adherence’. The assessment of adher-
ence will be undertaken using the full range of informa-
tion following completion of the process evaluation and
largely based on satisfaction in relation to each of the
moderating factors. Each intervention component will
be independently scored by three members of the re-
search team, before agreement on the final score for
each ward reached through discussion and consensus.
The final score will be available to be used as a covariate
in the final quantitative analysis, although it is antici-
pated that results will be presented with and without the
fidelity score.
Discussion
This study will determine whether the PRASE patient
safety intervention leads to improvements in the safety
and quality of care delivered to patients in acute settings,
over a 12-month period. This study will be one of the
largest patient safety randomised controlled trials ever
conducted, involving 32 hospital wards across three hos-
pital Trusts in the North of England. The findings will
be relevant to academics, health care professionals and
policy makers alike, and add to the evidence base on the
role of patients in patient safety. Specifically, it will fur-
ther our understanding of how patient feedback about
the safety of their care can be used to improve both cul-
tural and objective measures of patient safety, at a ward
level. This is an important step towards integrating the
‘patient voice’ into the assessment, monitoring and im-
provement of patient safety within hospitals. The PRASE
intervention has the potential to provide hospitals with
an evidence-based approach to the systematic collection
of patient views about the safety of their care. Further-
more, it provides a structured approach to how staff
might receive this feedback, consider it within the con-
text of other safety intelligence, and create action plans
to make targeted and patient-centred improvements on
their ward.
The successful completion of this trial will present a
number of challenges. First, within the current UK
healthcare landscape, which is undergoing unpre-
cedented reorganisation, and with constant pressure to
‘do more with less’, it is very possible that some staff
may be reluctant to engage with the intervention. Get-
ting healthcare professionals to see the benefits of sys-
tematically collecting patient feedback about safety will
be key to ensure engagement and reduce attrition from
the study. Second, a cornerstone of the intervention will
be how staff receive and act on patient feedback about
the safety of their care. A recent review of how staff use
patient reported outcome measures (PROMs) for service
improvement, suggested that one of the key issues was
the extent to which healthcare professionals valued thedata [50]. Specifically, across a number of studies it was
suggested that a significant barrier to using PROMs was
the issue of healthcare professionals not being open to
receiving feedback or changing their clinical practice in
light of the patient data [50]. This has been identified as
a barrier for patient involvement more widely, with the
‘staff know best’ mentality sometimes inhibiting patient-
centred care [51]. It is possible that the intervention
components relating to advising and supporting staff
about the intervention (for example, the ‘start-up’ ses-
sion, facilitation of the action planning meetings), may
play an important part in ameliorating these issues. The
process evaluation will be able to shed light on this role
after the trial is complete.
In summary, this paper has presented a protocol for a
large cluster randomised controlled trial, to investigate
the efficacy of using patient feedback about safety as a
means of achieving patient safety improvements. It will
provide some significant advancements in the emergent
field of patient involvement in patient safety, as well as
practical and robustly developed tools for use by health
services going forward.
Trial status
First patient recruited 7th May 2013. Recruitment of
patients is ongoing until September 2014.
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Additional file 1: Appendix 1. PMOS questionnaire. Appendix 2. PIRT
tool. Appendix 3. Example feedback report. Appendix 4. Summary of
trial process. Appendix 5. Staff safety culture questionnaire. Appendix 6.
PRASE intervention and process evaluation: trial summary diagram.
Appendix 7. Intervention fidelity assessment table.
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